Literature DB >> 3560780

Cytoprotection and prostaglandins.

A Robert.   

Abstract

Among substances producing gastrointestinal cytoprotection, prostaglandins are the most potent. They protect the mucosa after either exogenous administration or stimulation of endogenous release by the stomach. The first type is called "direct" cytoprotection, and the second "adaptive" cytoprotection. Certain agents are cytoprotective by a mechanism other than endogenous formation of prostaglandins. Depletion of the gastrointestinal tract of prostaglandins by administration of nonsteroidal antiinflammatory compounds or corticosteroids can lead to ulcer formation. The mechanism of cytoprotection is unknown. It may involve stimulation of bicarbonate and mucus secretion, protection of the gastric mucosal barrier, and increase in mucosal phospholipid surfactants, and maintenance in mucosal blood flow, increase in sulfhydryl agents or increase in cellular resistance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3560780

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  6 in total

1.  Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.

Authors:  Alessandra Gambero; Marta Maróstica; Tagliane Liza Becker; José Pedrazzoli
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

2.  Adaptive cytoprotection against deoxycholate-induced injury in human gastric cells in vitro: is there a role for endogenous prostaglandins?

Authors:  E R Kokoska; G S Smith; C L Rieckenberg; Y Deshpande; A Banan; T A Miller
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

Review 3.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 4.  Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future.

Authors:  Predrag Sikiric; Ki-Baik Hahm; Alenka Boban Blagaic; Ante Tvrdeic; Katarina Horvat Pavlov; Andrea Petrovic; Antonio Kokot; Slaven Gojkovic; Ivan Krezic; Domagoj Drmic; Rudolf Rucman; Sven Seiwerth
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

5.  Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats.

Authors:  Lidija Berkopic Cesar; Slaven Gojkovic; Ivan Krezic; Dominik Malekinusic; Helena Zizek; Lovorka Batelja Vuletic; Andreja Petrovic; Katarina Horvat Pavlov; Domagoj Drmic; Antonio Kokot; Josipa Vlainic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Gastrointest Pharmacol Ther       Date:  2020-11-08

6.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.